IPOPLUS

₹6,245.5

▼ -4 -0.06%

18 Jun 2026

NSE Listed · Pharmaceuticals

Procter & Gamble Health Limited (PGHL)

Volume: 686Avg Vol 1W: 708Avg Vol 1M: 2,59052W Range:₹4,707₹6,739
NSE BSE www.pghealthindia.com
₹6,245.5▼ 0.06%
Key Ratios
Updated just now
Market Cap—
Current Price₹6,245.5
Previous Close₹6,249.5
High / Low (52w)₹6,739 / ₹4,707
Volume686
Avg Vol (1W)708
Avg Vol (1M)2,590
Stock P/E27.31
Book Value₹315.99
Dividend Yield—
ROE—
ROA—
Revenue (TTM)₹1,408 Cr
Revenue Growth—
Profit Margin—
Total Debt—
Shares Outstanding—
Face Value₹10
EPS (TTM)₹56.99
P/B16.65
Debt / Equity—
50 DMA₹5,518.55
200 DMA₹5,244.51
Day change-0.06%
Price Chart
₹6,245.5▼ 0.72% · 1Y
₹6335₹477187K
2025-10-01
2026-06-16

20-day avg volume: 3K shares

Pros
  • Revenue grew 1490672411% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹370 Cr₹374 Cr₹325 Cr₹339 Cr₹311 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EBITDA₹129 Cr₹105 Cr₹114 Cr₹85 Cr₹76 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹95 Cr₹78 Cr₹89 Cr₹66 Cr₹61 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
EPS56.9946.7453.5439.8736.8654.7649.69.52843.439.517.9635.6646.338.324.8130.82733.420.49.540.935.729.428
Profit & Loss (Annual)
MetricMar 2026Mar 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020Dec 2019
Revenue₹1,408 Cr₹0 Cr₹0 Cr₹1,230 Cr₹0 Cr₹0 Cr₹0 Cr₹927 Cr
EBITDA₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr₹0 Cr
Net Profit₹327 Cr₹0 Cr₹0 Cr₹229 Cr₹193 Cr₹0 Cr₹0 Cr₹0 Cr
EPS—141121——107153—
Balance Sheet
MetricMar 2026Mar 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Total Assets₹841 Cr₹0 Cr₹794 Cr₹1,101 Cr₹888 Cr₹0 Cr₹0 Cr
Total Liabilities₹317 Cr₹0 Cr₹256 Cr₹350 Cr₹272 Cr₹0 Cr₹0 Cr
Equity₹525 Cr₹0 Cr₹538 Cr₹751 Cr₹616 Cr₹0 Cr₹0 Cr
Total Debt₹9 Cr₹0 Cr₹10 Cr₹12 Cr₹3 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2026Mar 2025Jun 2024Jun 2023Jun 2022Jun 2021Jun 2020
Operating₹338 Cr₹0 Cr₹228 Cr₹236 Cr₹170 Cr₹0 Cr₹0 Cr
Investing₹1 Cr₹0 Cr₹-7 Cr₹-21 Cr₹-26 Cr₹0 Cr₹0 Cr
Financing₹-344 Cr₹0 Cr₹-418 Cr₹-98 Cr₹-289 Cr₹0 Cr₹0 Cr
Free Cash Flow₹322 Cr₹0 Cr₹207 Cr₹194 Cr₹132 Cr₹0 Cr₹0 Cr
Shareholding
Promoter 51.82% Institutions 19.87% Public 28.31%
About Procter & Gamble Health Limited

Pharmaceuticals · Pharmaceuticals - Multinational

Procter & Gamble Health Limited manufactures and markets pharmaceuticals and chemical products in India and internationally. The company offers over-the-counter products, vitamins, minerals, and supplements. It offers its products under the Polybion, Cosome, Evion, Neurobion, Nasivion, Livogen, and Seven Seas brands. The company was formerly known as Merck Limited and changed its name to Procter & Gamble Health Limited in May 2019. Procter & Gamble Health Limited was incorporated in 1967 and is headquartered in Mumbai, India. Procter & Gamble Health Limited is a subsidiary of Procter & Gamble Overseas India B.V.

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search